Disposition of 28000 shares by Sarah Boyce of Avidity Biosciences at 27.4207 subject to Rule 16b-3
RNA Stock | USD 30.64 1.56 5.36% |
About 70 percent of all Avidity Biosciences' investors are curious in acquiring. The analysis of the overall investor sentiment regarding Avidity Biosciences suggests that a large number of traders are confidant. The current market sentiment, together with Avidity Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Avidity Biosciences stock news signals to limit their universe of possible portfolio assets.
Avidity |
Filed transaction by Avidity Biosciences Director, Officer: President And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Cash Flow Correlation
Avidity Biosciences' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Avidity Biosciences' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Avidity Biosciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Avidity Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Avidity Biosciences Historical Investor Sentiment
Investor biases related to Avidity Biosciences' public news can be used to forecast risks associated with an investment in Avidity. The trend in average sentiment can be used to explain how an investor holding Avidity can time the market purely based on public headlines and social activities around Avidity Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Avidity Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Avidity Biosciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Avidity Biosciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Avidity Biosciences.
Avidity Biosciences Fundamental Analysis
We analyze Avidity Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avidity Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avidity Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Avidity Biosciences is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Avidity Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Avidity Biosciences stock to make a market-neutral strategy. Peer analysis of Avidity Biosciences could also be used in its relative valuation, which is a method of valuing Avidity Biosciences by comparing valuation metrics with similar companies.
Peers
Avidity Biosciences Related Equities
SWTX | SpringWorks Therapeutics | 8.14 | ||||
PLRX | Pliant Therapeutics | 5.52 | ||||
RLAY | Relay Therapeutics | 4.92 | ||||
RVMD | Revolution Medicines | 4.25 | ||||
BDTX | Black Diamond | 3.61 | ||||
PTGX | Protagonist Therapeutics | 3.44 | ||||
AKRO | Akero Therapeutics | 2.87 | ||||
ARVN | Arvinas | 2.55 | ||||
PASG | Passage Bio | 1.96 | ||||
IGMS | IGM Biosciences | 1.49 | ||||
CGEM | Cullinan Oncology | 1.39 | ||||
STOK | Stoke Therapeutics | 1.75 | ||||
DAWN | Day One | 4.03 | ||||
MLYS | Mineralys Therapeutics, | 8.23 |
Complementary Tools for Avidity Stock analysis
When running Avidity Biosciences' price analysis, check to measure Avidity Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avidity Biosciences is operating at the current time. Most of Avidity Biosciences' value examination focuses on studying past and present price action to predict the probability of Avidity Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avidity Biosciences' price. Additionally, you may evaluate how the addition of Avidity Biosciences to your portfolios can decrease your overall portfolio volatility.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |